Cargando…
Recent Advances in Hepatitis B Treatment
Hepatitis B virus infection affects over 250 million chronic carriers, causing more than 800,000 deaths annually, although a safe and effective vaccine is available. Currently used antiviral agents, pegylated interferon and nucleos(t)ide analogues, have major drawbacks and fail to completely eradica...
Autores principales: | Prifti, Georgia-Myrto, Moianos, Dimitrios, Giannakopoulou, Erofili, Pardali, Vasiliki, Tavis, John E., Zoidis, Grigoris |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8147224/ https://www.ncbi.nlm.nih.gov/pubmed/34062711 http://dx.doi.org/10.3390/ph14050417 |
Ejemplares similares
-
Targeting Metalloenzymes: The “Achilles’ Heel” of Viruses and Parasites
por: Moianos, Dimitrios, et al.
Publicado: (2023) -
Novel Lipophilic Hydroxamates Based on Spirocarbocyclic Hydantoin Scaffolds with Potent Antiviral and Trypanocidal Activity
por: Pardali, Vasiliki, et al.
Publicado: (2023) -
Metal coordinating inhibitors of Rift Valley fever virus replication
por: Geerling, Elizabeth, et al.
Publicado: (2022) -
Recent advances in managing hepatitis B
por: McMahon, Brian J
Publicado: (2010) -
Recent Advances in the Management of Chronic Hepatitis B
por: Kim, Soo Ryang, et al.
Publicado: (2011)